Optimization of cardiovascular function by peptide bio-regulators
Cherkashin, V.A.; Semin, G.F.; Veretenko, A.A.
Klinicheskaia Meditsina 80(5): 30-34
2002
ISSN/ISBN: 0023-2149 PMID: 12087883 Document Number: 550788
Effects of peptide bioregulators (thymaline, epithalamine, cortexine) on systemic hemodynamics in cardiovascular and cerebrovascular affections were studied. Assessment of functional stability and quality of cardiovascular system regulation was made according to methodological principles of automatic regulation theory. Peptide bioregulators showed high effectiveness in the above patients who markedly improved their hemodynamic parameters.
Document emailed within 1 workday
Related Documents
Grosfeldowa, O.; Czarnecka, B.; Jackowska, M.; Kakolewska, J. 1970: Function regulators in clinical experience Czasopismo Stomatologiczne 23(4): 387-394Labiszewska-Jaruzelska, F.; Kuenstler, L. 1971: Changes in teleradiographic findings during treatment with function regulators Czasopismo Stomatologiczne 24(9): 1061-1065
Frol'kis, V.V. 1999: Invertors--intracellular regulators of plasma membrane function Fiziolohichnyi Zhurnal 45(1-2): 6-15
Istrate, A.N.; Mantsyzov, A.B.; Kozin, S.A.; Pol'shakov, V.I. 2010: Optimization of the methods for small peptide solution structure determination by NMR spectroscopy Molekuliarnaia Biologiia 44(6): 1075-1085
Morris, P.L.; Chen C L.; Feng, Z.M.; Vaughan, J.; Vale, W.W.; Bardin, C.W. 1991: The inhibin activin family and proopiomelanocortin derived peptides as intratesticular regulators of cellular function Haseltine, F P And J K Findlay (Ed ) Scientific Basis Of Fertility Regulation: Growth Factors in Fertility Regulation; Symposium on Potential Of Molecular Biology in Fertility Regulation: Growth Regulatory Factors, Bethesda, Maryland, Usa, September 22-24, 1988 Xxii+380p Cambridge University Press: Cambridge, England, Uk; New York, New York, Usa Illus 209-228
Yang, J.-l.; Gao, L.-l.; Zhu, P.; Hou, Q.; Wang, F.; Yu, W.-b.; Nie, T. 2012: Codon optimization and eukaryotic expression analysis of the analgesic peptide gene BmK AngM1 from Buthus martensii Karsch Yao Xue Xue Bao 47(10): 1389-1393
Ayadi-Zouari, D.; Kammoun, R.; Jemli, S.; Chouayekh, H.; Bejar, S. 2012: Secretion of cyclodextrin glucanotransferase in E. coli using Bacillus subtilis lipase signal peptide and optimization of culture medium Indian Journal of Experimental Biology 50(1): 72-79
Bykov, A.T.; Chernyshov, A.V. 2012: Optimization of preventive measures in the patients with risk factors of cardiovascular diseases Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2012(2): 3-6
Halapas, A.; Tenta, R.; Pantos, C.; Cokkinos, D.V.; Koutsilieris, M. 2003: Parathyroid hormone-related peptide and cardiovascular system In Vivo 17(5): 425-432
Tweden, K.S.; Harasaki, H.; Jones, M.; Blevitt, J.M.; Craig, W.S.; Pierschbacher, M.; Helmus, M.N. 1995: Accelerated healing of cardiovascular textiles promoted by an RGD peptide Journal of Heart Valve Disease 4(Suppl 1): S90-S97
Avogaro, A. 2010: Glucagon like peptide-1 and the cardiovascular system: pathophysiological mechanisms Giornale Italiano di Cardiologia 11(12 Suppl 2: 18s-25s
Sirén, A.L.; Feuerstein, G. 1988: Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat Journal of Pharmacology and Experimental Therapeutics 247(1): 69-78
Kubo, Y.; Kuwahara, S.; Tanikawa, K. 1980: Pancreatic Function Diagnostant (PFD): a pancreatic exocrine function test with synthetic peptide, BT-PABA Nihon Rinsho. Japanese Journal of Clinical Medicine 38(1): 45-50
Birkeland, S.A.; Elbirk, A.; Rohr, N.; Jørgensen, K.A. 1994: Optimization of cyclosporine monotherapy--long-term graft function Transplantation Proceedings 26(5): 2501-2506
Mühlberg, G.; Kahlert, G. 1970: Biostatistical study of the influence of the type i function regulators of Frankel and of the FKO activator on the angle formed by the palatal plane and the mandibular plane in the lateral teleroentgenologic picture Deutsche Stomatologie 20(6): 401-408
Takeda, N.; Hirata, Y. 2007: Efficacy and adverse reactions of atrial natriuretic peptide on kidney and cardiovascular system Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 110-114
Oudit, G.Y.; Butler, D.G. 1995: Cardiovascular effects of arginine vasotocin, atrial natriuretic peptide, and epinephrine in freshwater eels American Journal of Physiology 268(5 Pt 2): R1273-R1280
Casciani, G.; Ripanucci, G. 1984: Optimization of environmental sampling of quartziferous dust as a function of the limits and non-linearity of the diffractometric response La Medicina del Lavoro 75(3): 200-206
Fabbian, F.; Stabellini, N.; Sartori, S.; Molino, C.; Russo, G.; Russo, M.; Cantelli, S.; Catizone, L. 2006: Role of B-type natriuretic peptide in cardiovascular state monitoring in a hemodialysis patient with primary amyloidosis International Journal of Artificial Organs 29(8): 745-749
Kangawa, K.; Minamino, N.; Matsuo, H. 2004: Structure and function of the natriuretic peptide family Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 10-17